ADVENTRX Pharmaceuticals (ANX) Reports Q3 Loss of $0.07
Tweet
Share
E-mailGet Alerts ANX Hot Sheet
Join SI Premium – FREE
ADVENTRX Pharmaceuticals (NYSE: ANX) reported Q3 EPS of ($0.07), versus ($0.13) reported last year.
For earnings history and earnings-related data on ADVENTRX Pharmaceuticals (ANX) click here.
For earnings history and earnings-related data on ADVENTRX Pharmaceuticals (ANX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl leads $2.4 billion debt deal for Iren data center
- AiRWA receives Nasdaq deficiency notice over late 10-K filing
- Hafnia Limited (HAFN) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
